ACA
RCKT icon

Apis Capital Advisors’s Rocket Pharmaceuticals RCKT Stock Holding History

Apis Capital Advisors’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$94K Buy
+2,500
New +$115K 0.13% 40

Other funds holding RCKT

DPA
Devon Park Associates $30.8M AUM 0.85% 1-Year Est. Return
RCP
Rho Capital Partners New York $20.4M AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Apis Capital Advisors's RCKT Position: Q3 2015 in Review

Apis Capital Advisors opened a new position in Rocket Pharmaceuticals (RCKT) in Q3 2015: 2,500 shares worth $94K. The stake represents 0.13% of the portfolio and ranks #40 among its holdings.

53 funds tracked by Wall St. Rank hold RCKT as of Q3 2015.

  • Apis Capital Advisors held 2,500 shares of Rocket Pharmaceuticals worth $94K as of Q3 2015.
  • Rocket Pharmaceuticals was a new Apis Capital Advisors position in Q3 2015.
  • Rocket Pharmaceuticals made up 0.13% of Apis Capital Advisors's portfolio in Q3 2015, its #40 holding.
  • 53 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q3 2015.

Based on Apis Capital Advisors's 13F filing for Q3 2015, filed 16 Nov 2015.